Immediate Impact
28 standout
Citing Papers
An Update on the Nitrogen Heterocycle Compositions and Properties of U.S. FDA-Approved Pharmaceuticals (2013–2023)
2024 Standout
Properties of FDA-approved small molecule protein kinase inhibitors: A 2024 update
2024 Standout
Works of Cecelia Perkins being referenced
A phase 2 study of brentuximab vedotin in patients with CD30-positive advanced systemic mastocytosis
2019
Efficacy and safety of midostaurin in patients with advanced systemic mastocytosis: 10-year median follow-up of a phase II trial
2017
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Cecelia Perkins | 49 | 37 | 73 | 87 | 10 | 147 | |
| Juliana Schwaab | 59 | 56 | 37 | 56 | 13 | 135 | |
| Amy Meng | 43 | 43 | 113 | 60 | 9 | 225 | |
| MA Brach | 18 | 81 | 26 | 100 | 10 | 219 | |
| Rika Kato | 12 | 14 | 54 | 113 | 10 | 202 | |
| Velia Gerl | 10 | 10 | 59 | 107 | 7 | 165 | |
| Julian Staniek | 18 | 18 | 40 | 85 | 7 | 157 | |
| Ilaria Farina | 22 | 41 | 101 | 74 | 10 | 156 | |
| Sophie Roenneberg | 25 | 10 | 73 | 122 | 9 | 231 | |
| Carlos de la Calle‐Fabregat | 12 | 41 | 39 | 89 | 10 | 219 | |
| Nemanja Damjanov | 22 | 39 | 74 | 74 | 7 | 197 |
All Works
Login with ORCID to disown or claim papers
Loading papers...